Small caps round-up: Orchid, Iofina, Phytopharm
Cash is extremely tight at the Bulgaria focused property company Orchid Developments Group, especially after a recent planned sale asset failed to go ahead for reasons beyond the control of Orchid. The firm has warned that it 'cannot be certain that it can continue to operate with the full support of its creditors', meaning that its cash position is now more uncertain than previously stated. Consequently, the group is now considering the best way to address its immediate working capital needs.
Cash is extremely tight at the Bulgaria focused property company Orchid Developments Group, especially after a recent planned sale asset failed to go ahead for reasons beyond the control of Orchid. The firm has warned that it 'cannot be certain that it can continue to operate with the full support of its creditors', meaning that its cash position is now more uncertain than previously stated. Consequently, the group is now considering the best way to address its immediate working capital needs.
Iodine maker Iofina has successfully commissioned its IO#1 plant, marking a significant milestone for the firm. The tie-in to the electricity grid was completed on schedule in early August. The firm has now commenced processing iodine-rich brine from the producer's salt water disposal site and the company is now on track to become a major iodine producer.
Phytopharm, a developer of pharmaceuticals, is expecting the headline results from its phase two clinical study on its Cogane product in patients with Parkinson's disease in February 2013, saying it has already demonstrated efficacy in the "gold standard" pre-clinical model of ALS, the most common form of motor neurone disease. The firm is growing confident that the drug offers a potential treatment for the condition. The company is now preparing for a phase one study to evaluate Cogane solid dose formulations for up to 28 days.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
NR
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Do you qualify for the Winter Fuel Payment if you live abroad?
The Winter Fuel Payment will be means tested for expats living in Europe, in line with the new rules impacting those in the UK. But a quirk in the system means not all countries are eligible.
By Katie Williams Published
-
What the Employment Rights Bill means for your job
New workplace reforms are set to give employees new rights to benefits and flexible working
By Marc Shoffman Published